How Can We Personalize the Delivery of Onabotulinumtoxin‐A for Patients With Neurogenic Lower Urinary Tract Dysfunction?

Key Points

• The study aims to explore how to personalize the delivery of botulinum toxin-A for optimizing treatment of neurogenic lower urinary tract dysfunction.
• Examined various neurologic etiologies affecting treatment response
• Evaluated the functional status of patients prior to treatment
• Developed individualized treatment strategies based on assessment results
• Individualized treatment strategies led to better health outcomes
• Tailoring therapy improved patient satisfaction
• Greater effectiveness observed in patients with specific neurologic conditions

Abstract